Derry Mercer

Derry Mercer has extensive work experience in the field of antimicrobial research and development. From 1996 to 2004, Mercer served as a Principle Investigator at the Rowett Research Institute. In 2005, Mercer joined NovaBiotics Ltd as a Principal Scientist, where they focused on antimicrobial drug discovery and development. They worked on various aspects of drug discovery, including microbiology, molecular biology, toxicity, and drug design. Mercer held this position until 2023 while also taking on additional roles as Head of Antimicrobials and Responsable du Programme Antimicrobiens at BIOASTER. In 2020, Mercer became a Trustee at the Biochemical Society and an Honorary Policy Officer. Additionally, Mercer served as a Visiting Professor at Robert Gordon University starting in 2013.

Derry Mercer completed a Bachelor of Science (BSc) (Hons) degree in Microbiology, General from the University of Liverpool. This education took place from 1987 to 1991. Following this, Derry pursued a Doctor of Philosophy (Ph.D.) degree in Microbiology, General from the same university. This doctoral program lasted from 1991 to 1994.